Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells DOI Creative Commons
Ahmed A. H. Abdellatif, Ahmed Abdelfattah, Mahmoud A. Younis

et al.

Nanotechnology Reviews, Journal Year: 2023, Volume and Issue: 12(1)

Published: Jan. 1, 2023

Graphical abstract

Language: Английский

Review of Flexible Wearable Sensor Devices for Biomedical Application DOI Creative Commons
Xueli Nan, Xin Wang,

Tongtong Kang

et al.

Micromachines, Journal Year: 2022, Volume and Issue: 13(9), P. 1395 - 1395

Published: Aug. 26, 2022

With the development of cross-fertilisation in various disciplines, flexible wearable sensing technologies have emerged, bringing together many such as biomedicine, materials science, control and communication technology. Over past few years, multiple types devices that are widely used for detection human physiological signals has proven strong biocompatibility a great potential further development. These include electronic skin patches, soft robots, bio-batteries, personalised medical devices. In this review, we present an updated overview emerging sensor biomedical applications comprehensive summary research progress sensors. First, describe selection fabrication their excellent electrochemical properties. We evaluate mechanisms by which these work, then categorise compare unique advantages variety from perspective vitro vivo sensing, well some exciting body. Finally, summarise opportunities challenges field

Language: Английский

Citations

48

Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery DOI
Qimanguli Saiding, Zhongyang Zhang, Shuying Chen

et al.

Advanced Drug Delivery Reviews, Journal Year: 2023, Volume and Issue: 203, P. 115116 - 115116

Published: Oct. 21, 2023

Language: Английский

Citations

28

Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders DOI
Biswajeet Acharya, Amulyaratna Behera,

Suchismeeta Behera

et al.

ACS Applied Bio Materials, Journal Year: 2024, Volume and Issue: 7(3), P. 1336 - 1361

Published: Feb. 27, 2024

Over the past decade, nanotechnology has seen extensive integration into biomedical applications, playing a crucial role in biodetection, drug delivery, and diagnostic imaging. This is especially important reproductive health care, which become an emerging significant area of research. Global concerns have intensified around disorders such as infertility, endometriosis, ectopic pregnancy, erectile dysfunction, benign prostate hyperplasia, sexually transmitted infections, cancers. Nanotechnology presents promising solutions to address these by introducing innovative tools techniques, facilitating early detection, targeted improved imaging capabilities. Through utilization nanoscale materials devices, researchers can craft treatments that are not only more precise but also effective, significantly enhancing outcomes healthcare. Looking forward, future medicine holds immense potential for reshaping diagnostics, personalized therapies, fertility preservation. The nanotechnology-driven delivery systems anticipated elevate treatment effectiveness, minimize side effects, offer patients therapies efficient. review aims delve various types, properties, preparation techniques nanocarriers specifically designed context disorders, shedding light on current landscape directions this dynamic field.

Language: Английский

Citations

15

A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles DOI Creative Commons
Valentina Francia, Yao Zhang, Miffy H. Y. Cheng

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2024, Volume and Issue: 121(11)

Published: March 4, 2024

Lipid nanoparticle (LNP) formulations are a proven method for the delivery of nucleic acids gene therapy as exemplified by worldwide rollout LNP-based RNAi therapeutics and mRNA vaccines. However, targeting specific tissues or cells is still major challenge. After LNP administration, LNPs interact with biological fluids (i.e., blood), components which adsorb onto surface forming layer biomolecules termed “biomolecular corona (BMC)” affects stability, biodistribution, tissue tropism. The mechanisms BMC influences tissue- cell-specific remains largely unknown, due to technical challenges in isolating their from complex media. In this study, we present new technique that utilizes magnetic isolate LNP–corona complexes unbound proteins human serum. First, developed formulation, containing >40 superparamagnetic iron oxide nanoparticles (IONPs)/LNP, resulting (IOLNPs) displayed similar particle size morphology loaded acids. We further demonstrated isolation IOLNPs corresponding using separation (MS) system. profile MS system was compared exclusion column chromatography analyzed via mass spectrometry, revealing differences protein abundances. This approach enabled mild versatile its corona, while maintaining structural integrity. identification associated an intact provides insight into interactions fluids.

Language: Английский

Citations

13

Expanding RNAi to Kidneys, Lungs, and Spleen via Selective ORgan Targeting (SORT) siRNA Lipid Nanoparticles DOI Creative Commons
Amogh Vaidya, Stephen D. Moore, Sumanta Chatterjee

et al.

Advanced Materials, Journal Year: 2024, Volume and Issue: 36(35)

Published: June 21, 2024

Inhibition of disease-causing mutations using RNA interference (RNAi) has resulted in clinically approved medicines with additional candidates late stage trials. However, targetable tissues currently preclinical development are limited to liver following systemic intravenous (IV) administration because predictable delivery siRNA non-liver remains an unsolved challenge. Here, evidence durable extrahepatic gene silencing enabled by Selective ORgan Targeting lipid nanoparticles (siRNA SORT LNPs) the kidneys, lungs, and spleen is provided. LNPs excel at dose-dependent tissue-enriched endogenous targets resulting 60%-80% maximal knockdown after a single IV injection up 88% downregulation protein expression mouse lungs two doses. To examine potency unbiased organ targeting, B6.129

Language: Английский

Citations

12

Role of oxidative stress in mitochondrial dysfunction and their implications in intervertebral disc degeneration: Mechanisms and therapeutic strategies DOI Creative Commons
Hao Zhou,

Chenyu Wu,

Yuxin Jin

et al.

Journal of Orthopaedic Translation, Journal Year: 2024, Volume and Issue: 49, P. 181 - 206

Published: Oct. 16, 2024

Language: Английский

Citations

11

Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer’s Diseases DOI
Bahareh Farasati Far,

Maryam Safaei,

Ali Pourmolaei

et al.

ACS Applied Bio Materials, Journal Year: 2024, Volume and Issue: 7(6), P. 3535 - 3555

Published: May 20, 2024

Alzheimer's disease (AD) is a neurological condition currently with 47 million people suffering from it globally. AD might have many reasons such as genetic issues, environmental factors, and Aβ accumulation, which the biomarker of disease. Since primary reason unknown, there no targeted treatment at moment, but ongoing research aims to slow its progression by managing amyloid-beta peptide production rather than symptomatic improvement. phytochemicals been demonstrated possess antioxidant, anti-inflammatory, neuroprotective properties, they may target multiple pathological factors can reduce risk Curcumin, phytochemical found in turmeric known for free radical scavenging an antiamyloid treating AD, has come under investigation. Although low bioavailability limits efficacy, prominent drug delivery system (DDS) desired overcome it. Hence, potency lipid-based nanoparticles encapsulating curcumin (LNPs-CUR) considered this study promising DDS. In vivo studies animal models indicate LNPs-CUR effectively amyloid plaque formation, leading cognitive enhancement reduced toxicity compared CUR. However, deeper understanding CUR's pharmacokinetics safety profile crucial before be medicine. Future investigations explore combination NPs other therapeutic agents increase their efficacy cases. This review provides current position CUR therapy paradigm, DDS suggestions CUR, previous point analytical view focused on advantages challenges.

Language: Английский

Citations

10

Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy DOI

Setareh Soroudi,

Mahmoud Reza Jaafari,

Leila Arabi

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 372, P. 113 - 140

Published: June 15, 2024

Language: Английский

Citations

10

Emerging strategies for nanomedicine in autoimmunity DOI
Ajay S. Thatte, Margaret M. Billingsley, Drew Weissman

et al.

Advanced Drug Delivery Reviews, Journal Year: 2024, Volume and Issue: 207, P. 115194 - 115194

Published: Feb. 10, 2024

Language: Английский

Citations

9

mRNA vaccine designs for optimal adjuvanticity and delivery DOI Creative Commons
Yuki Mochida, Satoshi Uchida

RNA Biology, Journal Year: 2024, Volume and Issue: 21(1), P. 1 - 27

Published: March 26, 2024

Adjuvanticity and delivery are crucial facets of mRNA vaccine design. In modern vaccines, adjuvant functions integrated into nanoparticles, allowing the co-delivery antigen adjuvants in a unified, all-in-one formulation. this formulation, many vaccines utilize immunostimulating properties carrier components, including lipids polymers, as adjuvants. However, careful design is necessary, excessive adjuvanticity activation improper innate immune signalling can conversely hinder vaccination efficacy trigger adverse effects. also require systems to achieve expression antigen-presenting cells (APCs) within lymphoid organs. Some directly target APCs organs, while others rely on migration draining lymph nodes after taking up vaccines. This review explores current mechanistic understanding these processes ongoing efforts improve safety based understanding.

Language: Английский

Citations

9